Clinical trials are a fundamental step in the development of new therapies. At Infinity, our clinical development strategy is to develop best-in-class drug candidates for the treatment of cancer and rapidly bring them to market to make them available to patients. We collaborate with world-renowned clinical investigators and take an adaptive and innovative approach to clinical trial design to ensure that our clinical strategy is focused and streamlined.

We make our development decisions based on a rigorous scientific interpretation of clinical data, a growing understanding of the biology of our drug targets, and the best interests of patients. Our focus is to expand the development of our drug candidates into additional indications, earlier lines of therapy, and combination studies with other approved agents in order to broaden their market potential and enhance the lives of patients living with cancer.

For specific information on our ongoing clinical trials, please contact:

Jill Goddard, Associate Director, Clinical Operations
Phone: 617.453.1014
Email: clinical.request@infi.com